HOLLY SPRINGS, North Carolina/TOKYO -- Japan's Fujifilm has inaugurated one of the largest contract biopharmaceutical production sites in the U.S., an ambitious response to the Trump administration's call to bring drug manufacturing back to the country.
Pharmaceuticals
Fujifilm aims to become 'TSMC of biopharma' with new US plant
One of the largest contract drugmaking facilities in the country set to open
The upper portion of a group of four 20,000-liter bioreactor tanks that span three floors of the facility. (Photo by Yuji Ohira)
Read Next
Latest on Pharmaceuticals
